These data all support the notion that the absence of the CHRM4 leads to increased dopaminergic activity in the CNS which is also argued to be involved in the genesis of psychotic symptoms in people with schizophrenia (Carlsson, 1977). This evidence concerns the gene CHRM4 and schizophrenia.